Reduced global headcount by approximately 500 positions year-over-year to create a leaner, more efficient organizational structure that allows growth to drop through to the bottom line.Transitioned the dry eye franchise from a launch phase to a growth phase, focusing on targeted investments and selling excellence to drive Miebo and Xiidra performance.Leveraged a diversified 'end-to-end' eye health portfolio to outperform the global contact lens market, growing 7% in China despite broader consumer softness i ...